{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:55:21Z","timestamp":1783047321861,"version":"3.54.6"},"reference-count":225,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100006143","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001738","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Adaptive immune cells play an important role in mounting antigen-specific antitumor immunity. The contribution of innate immune cells such as monocytes, macrophages, natural killer (NK) cells, dendritic cells, and gamma-delta T cells is well studied in cancer immunology. NK cells are innate lymphoid cells that show effector and regulatory function in a contact-dependent and contact-independent manner. The cytotoxic function of NK cells plays an important role in killing the infected and transformed host cells and controlling infection and tumor growth. However, several studies have also ascribed the role of NK cells in inducing pathophysiology in autoimmune diseases, promoting immune tolerance in the uterus, and antitumor function in the tumor microenvironment. We discuss the fundamentals of NK cell biology, its distribution in different organs, cellular and molecular interactions, and its cytotoxic and noncytotoxic functions in cancer biology. We also highlight the use of NK cell\u2013based adoptive cellular therapy in cancer.<\/jats:p>","DOI":"10.1093\/jleuko\/qiad126","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T11:27:15Z","timestamp":1697023635000},"page":"235-252","source":"Crossref","is-referenced-by-count":5,"title":["Effector and cytolytic function of natural killer cells in anticancer immunity"],"prefix":"10.1093","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-972X","authenticated-orcid":false,"given":"Surojit","family":"Karmakar","sequence":"first","affiliation":[{"name":"Laboratory of Autoimmunity and Tolerance, National Centre for Cell Science , Ganeshkhind , Pune, MH-411007, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7509-908X","authenticated-orcid":false,"given":"Amrita","family":"Mishra","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Tolerance, National Centre for Cell Science , Ganeshkhind , Pune, MH-411007, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-6084","authenticated-orcid":false,"given":"Pradipta","family":"Pal","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Tolerance, National Centre for Cell Science , Ganeshkhind , Pune, MH-411007, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3799-3603","authenticated-orcid":false,"given":"Girdhari","family":"Lal","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Tolerance, National Centre for Cell Science , Ganeshkhind , Pune, MH-411007, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"2024012011563164600_qiad126-B1","first-page":"117","article-title":"Development and function of natural killer cells and its importance in cancer immunotherapy","volume-title":"Immunology","author":"Paul","year":"2017"},{"key":"2024012011563164600_qiad126-B2","first-page":"471","article-title":"Lysis of homologous cells by sensitized lymphocytes in tissue culture","volume":"27","author":"Rosenau","year":"1961","journal-title":"J Natl Cancer Inst."},{"issue":"4","key":"2024012011563164600_qiad126-B3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/bjc.1966.95","article-title":"Antigenicity of carcinogen-induced and spontaneous tumors in inbred mice","volume":"20","author":"Smith","year":"1966","journal-title":"Br J Cancer."},{"key":"2024012011563164600_qiad126-B4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fimmu.2012.00347","article-title":"Natural killer cell distribution and trafficking in human tissues","volume":"3","author":"Carrega","year":"2012","journal-title":"Front Immunol."},{"key":"2024012011563164600_qiad126-B5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front Immunol."},{"key":"2024012011563164600_qiad126-B6","first-page":"701","article-title":"NK Cells in autoimmune diseases: protective or pathogenic?","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"2024012011563164600_qiad126-B7","doi-asserted-by":"crossref","first-page":"e1235106","DOI":"10.1080\/2162402X.2016.1235106","article-title":"Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells","volume":"5","author":"Paul","year":"2016","journal-title":"Oncoimmunology"},{"key":"2024012011563164600_qiad126-B8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fimmu.2017.00360","article-title":"Modeling human natural killer cell development in the era of innate lymphoid cells","volume":"8","author":"Scoville","year":"2017","journal-title":"Front Immunol."},{"issue":"4","key":"2024012011563164600_qiad126-B9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1084\/jem.20132398","article-title":"The transcription factor E4bp4\/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression","volume":"211","author":"Male","year":"2014","journal-title":"J Exp Med"},{"issue":"6","key":"2024012011563164600_qiad126-B10","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M","article-title":"Identification of committed NK cell progenitors in adult murine bone marrow","volume":"31","author":"Rosmaraki","year":"2001","journal-title":"Eur J Immunol."},{"issue":"20","key":"2024012011563164600_qiad126-B11","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/blood-2011-04-348912","article-title":"Identification of the earliest natural killer cell\u2013committed progenitor in murine bone marrow","volume":"118","author":"Fathman","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2024012011563164600_qiad126-B12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.immuni.2015.12.007","article-title":"The Helix-loop-Helix protein ID2 governs NK cell fate by tuning their sensitivity to interleukin-15","volume":"44","author":"Delconte","year":"2016","journal-title":"Immunity"},{"issue":"10","key":"2024012011563164600_qiad126-B13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/ni.3248","article-title":"TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow","volume":"16","author":"Yang","year":"2015","journal-title":"Nat Immunol."},{"key":"2024012011563164600_qiad126-B14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coi.2016.01.007","article-title":"Development and maturation of natural killer cells","volume":"39","author":"Geiger","year":"2016","journal-title":"Curr Opin Immunol."},{"key":"2024012011563164600_qiad126-B15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fimmu.2017.00130","article-title":"Regulation of murine natural killer cell development","volume":"8","author":"Goh","year":"2017","journal-title":"Front Immunol."},{"issue":"6","key":"2024012011563164600_qiad126-B16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ni796","article-title":"In vivo developmental stages in murine natural killer cell maturation","volume":"3","author":"Kim","year":"2002","journal-title":"Nat Immunol."},{"issue":"2","key":"2024012011563164600_qiad126-B17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.20051986","article-title":"Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity","volume":"203","author":"Ito","year":"2006","journal-title":"J Exp Med."},{"issue":"2","key":"2024012011563164600_qiad126-B18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.celrep.2014.12.025","article-title":"Homeostatic control of memory cell progenitors in the natural killer cell lineage","volume":"10","author":"Kamimura","year":"2015","journal-title":"Cell Rep."},{"issue":"8","key":"2024012011563164600_qiad126-B19","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.4049\/jimmunol.178.8.4764","article-title":"NK Cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation","volume":"178","author":"Huntington","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"2024012011563164600_qiad126-B20","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.176.3.1517","article-title":"CD27 Dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity","volume":"176","author":"Hayakawa","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"2024012011563164600_qiad126-B21","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/cancers12061591","article-title":"Transcriptional regulation of natural killer cell development and functions","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)."},{"issue":"12","key":"2024012011563164600_qiad126-B22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","article-title":"Location and cellular stages of natural killer cell development","volume":"34","author":"Yu","year":"2013","journal-title":"Trends Immunol."},{"issue":"3","key":"2024012011563164600_qiad126-B23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/17534259211001512","article-title":"Human NK cells: from development to effector functions","volume":"27","author":"Arachchige","year":"2021","journal-title":"Innate Immun."},{"issue":"1","key":"2024012011563164600_qiad126-B24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1521-4141(200101)31:1<233::AID-IMMU233>3.0.CO;2-4","article-title":"Identification of NKp80, a novel triggering molecule expressed by human NK cells","volume":"31","author":"Vitale","year":"2001","journal-title":"Eur J Immunol."},{"issue":"2","key":"2024012011563164600_qiad126-B25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.celrep.2016.05.095","article-title":"NKp80 defines a critical step during human natural killer cell development","volume":"16","author":"Freud","year":"2016","journal-title":"Cell Rep."},{"key":"2024012011563164600_qiad126-B26","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3389\/fimmu.2019.01812","article-title":"On the way to become a natural killer cell","volume":"10","author":"Di Vito","year":"2019","journal-title":"Front Immunol."},{"issue":"4","key":"2024012011563164600_qiad126-B27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright Natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"issue":"10","key":"2024012011563164600_qiad126-B28","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"issue":"10","key":"2024012011563164600_qiad126-B29","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","article-title":"CD56bright Cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","author":"Jacobs","year":"2001","journal-title":"Eur J Immunol."},{"issue":"13","key":"2024012011563164600_qiad126-B30","doi-asserted-by":"crossref","first-page":"e162530","DOI":"10.1172\/JCI162530","article-title":"T-BET and EOMES sustain mature human NK cell identity and antitumor function","volume":"133","author":"Wong","year":"2023","journal-title":"J Clin Invest"},{"issue":"9","key":"2024012011563164600_qiad126-B31","doi-asserted-by":"crossref","first-page":"107720","DOI":"10.1016\/j.celrep.2020.107720","article-title":"Stage-Specific requirement for eomes in mature NK cell homeostasis and cytotoxicity","volume":"31","author":"Wagner","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"2024012011563164600_qiad126-B32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2011.11.016","article-title":"The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation","volume":"36","author":"Gordon","year":"2012","journal-title":"Immunity"},{"issue":"7","key":"2024012011563164600_qiad126-B33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41590-019-0388-z","article-title":"The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc","volume":"20","author":"Dong","year":"2019","journal-title":"Nat Immunol"},{"issue":"1","key":"2024012011563164600_qiad126-B34","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat Commun."},{"issue":"7","key":"2024012011563164600_qiad126-B35","doi-asserted-by":"crossref","first-page":"e202302069","DOI":"10.26508\/lsa.202302069","article-title":"Myc controls NK cell development, IL-15\u2013driven expansion, and translational machinery","volume":"6","author":"Khameneh","year":"2023","journal-title":"Life Sci Alliance"},{"key":"2024012011563164600_qiad126-B36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0065-3233(04)68004-1","article-title":"Shared cytokine signaling receptors: structural insights from the gp130 system","volume":"68","author":"Boulanger","year":"2004","journal-title":"Adv Protein Chem."},{"issue":"8","key":"2024012011563164600_qiad126-B37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ni1487","article-title":"Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1","volume":"8","author":"Huntington","year":"2007","journal-title":"Nat Immunol"},{"issue":"8","key":"2024012011563164600_qiad126-B38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20021836","article-title":"Interleukin (IL)-15R\u03b1\u2013deficient natural killer cells survive in normal but not IL-15R\u03b1\u2013deficient mice","volume":"197","author":"Koka","year":"2003","journal-title":"J Exp Med."},{"issue":"5","key":"2024012011563164600_qiad126-B39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(02)00429-6","article-title":"IL-15R\u03b1 recycles and presents IL-15 in trans to neighboring cells","volume":"17","author":"Dubois","year":"2002","journal-title":"Immunity"},{"issue":"3","key":"2024012011563164600_qiad126-B40","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.4049\/jimmunol.173.3.1681","article-title":"Natural, proteolytic release of a soluble form of human IL-15 receptor \u03b1-chain that behaves as a specific, high affinity IL-15 antagonist","volume":"173","author":"Mortier","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"2024012011563164600_qiad126-B41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.1998.tb01229.x","article-title":"Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems","volume":"165","author":"Williams","year":"1998","journal-title":"Immunol Rev."},{"issue":"3","key":"2024012011563164600_qiad126-B42","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4049\/jimmunol.174.3.1213","article-title":"Roles for common cytokine receptor \u03b3-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo","volume":"174","author":"Vosshenrich","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"2024012011563164600_qiad126-B43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V98.3.877","article-title":"Defective expression of the interleukin-2\/interleukin-15 receptor \u03b2 subunit leads to a natural killer cell\u2013deficient form of severe combined immunodeficiency","volume":"98","author":"Gilmour","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2024012011563164600_qiad126-B44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8T cell lineages in interleukin 15\u2013deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J Exp Med."},{"issue":"5","key":"2024012011563164600_qiad126-B45","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"issue":"2","key":"2024012011563164600_qiad126-B46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.193.2.219","article-title":"Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells","volume":"193","author":"Fehniger","year":"2001","journal-title":"J Exp Med."},{"issue":"4","key":"2024012011563164600_qiad126-B47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2567.2007.02730.x","article-title":"Interleukin-21 activates human natural killer cells and modulates their surface receptor expression","volume":"123","author":"Skak","year":"2008","journal-title":"Immunology"},{"issue":"1","key":"2024012011563164600_qiad126-B48","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1038\/s41598-022-19227-z","article-title":"Changes in immunological parameters by ageing in rural healthy Indian adults and their associations with sex and lifestyle","volume":"12","author":"Agarwal","year":"2022","journal-title":"Sci Rep."},{"issue":"4","key":"2024012011563164600_qiad126-B49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5114\/ceji.2021.109846","article-title":"Gender as a factor affecting NK cell activity in patients successfully treated for chronic hepatitis C with direct-acting antivirals","volume":"46","author":"Zientarska","year":"2021","journal-title":"Cent Eur J Immunol"},{"issue":"10","key":"2024012011563164600_qiad126-B50","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2024012011563164600_qiad126-B51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12326","article-title":"How sex and age affect immune responses, susceptibility to infections, and response to vaccination","volume":"14","author":"Giefing-Kroll","year":"2015","journal-title":"Aging Cell"},{"issue":"6","key":"2024012011563164600_qiad126-B52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ygeno.2006.07.016","article-title":"X chromosome gene expression in human tissues: male and female comparisons","volume":"88","author":"Talebizadeh","year":"2006","journal-title":"Genomics"},{"key":"2024012011563164600_qiad126-B53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fcell.2019.00219","article-title":"X inactivation and Escape: epigenetic and structural features","volume":"7","author":"Fang","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"2024012011563164600_qiad126-B54","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41590-023-01463-8","article-title":"The X-linked epigenetic regulator UTX controls NK cell-intrinsic sex differences","volume":"24","author":"Cheng","year":"2023","journal-title":"Nat Immunol"},{"issue":"2","key":"2024012011563164600_qiad126-B55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ni.3644","article-title":"The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells","volume":"18","author":"Beyaz","year":"2017","journal-title":"Nat Immunol"},{"issue":"2","key":"2024012011563164600_qiad126-B56","doi-asserted-by":"crossref","first-page":"108966","DOI":"10.1016\/j.celrep.2021.108966","article-title":"UTX Promotes CD8(+) T cell-mediated antiviral defenses but reduces T cell durability","volume":"35","author":"Mitchell","year":"2021","journal-title":"Cell Rep."},{"key":"2024012011563164600_qiad126-B57","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/ITT.S306109","article-title":"Key activating and inhibitory ligands involved in the mobilization of natural killer cells for cancer immunotherapies","volume":"10","author":"Karmakar","year":"2021","journal-title":"Immunotargets Ther."},{"issue":"4","key":"2024012011563164600_qiad126-B58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/cmi.2016.26","article-title":"NK Cell education via nonclassical MHC and non-MHC ligands","volume":"14","author":"He","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"2024012011563164600_qiad126-B59","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nri1863","article-title":"Self-tolerance of natural killer cells","volume":"6","author":"Raulet","year":"2006","journal-title":"Nat Rev Immunol."},{"issue":"4","key":"2024012011563164600_qiad126-B60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.it.2009.01.006","article-title":"NK Cell education: not an on-off switch but a tunable rheostat","volume":"30","author":"Brodin","year":"2009","journal-title":"Trends Immunol"},{"issue":"3","key":"2024012011563164600_qiad126-B61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2008.12.019","article-title":"A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education","volume":"30","author":"Chalifour","year":"2009","journal-title":"Immunity"},{"issue":"10","key":"2024012011563164600_qiad126-B62","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.4049\/jimmunol.1301971","article-title":"Education of murine NK cells requires both cis and trans recognition of MHC class I molecules","volume":"191","author":"Bessoles","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"2024012011563164600_qiad126-B63","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1073\/pnas.0607418104","article-title":"Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell\/target cell contact","volume":"104","author":"Back","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024012011563164600_qiad126-B64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fimmu.2016.00176","article-title":"Signaling in effector lymphocytes: insights toward safer immunotherapy","volume":"7","author":"Rajasekaran","year":"2016","journal-title":"Front Immunol."},{"issue":"5","key":"2024012011563164600_qiad126-B65","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell Mol Immunol."},{"issue":"1","key":"2024012011563164600_qiad126-B66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.20.092501.134942","article-title":"KIR: diverse, rapidly evolving receptors of innate and adaptive immunity","volume":"20","author":"Vilches","year":"2002","journal-title":"Annu Rev Immunol."},{"issue":"6669","key":"2024012011563164600_qiad126-B67","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"key":"2024012011563164600_qiad126-B68","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","article-title":"The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy","volume":"8","author":"Paul","year":"2017","journal-title":"Front Immunol."},{"key":"2024012011563164600_qiad126-B69","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fimmu.2018.00441","article-title":"NKG2D: a master regulator of immune cell responsiveness","volume":"9","author":"Wensveen","year":"2018","journal-title":"Front Immunol."},{"issue":"3","key":"2024012011563164600_qiad126-B70","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK Cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"2024012011563164600_qiad126-B71","first-page":"402","article-title":"The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses","volume":"3","author":"Barao","year":"2012","journal-title":"Front Immunol."},{"issue":"10","key":"2024012011563164600_qiad126-B72","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.4049\/jimmunol.0901644","article-title":"Tumor immunoediting by NKp46","volume":"184","author":"Elboim","year":"2010","journal-title":"J Immunol"},{"key":"2024012011563164600_qiad126-B73","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2019.00909","article-title":"The natural cytotoxicity receptors in health and disease","volume":"10","author":"Barrow","year":"2019","journal-title":"Front Immunol."},{"issue":"13","key":"2024012011563164600_qiad126-B74","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1073\/pnas.092258599","article-title":"Recognition of a virus-encoded ligand by a natural killer cell activation receptor","volume":"99","author":"Smith","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2024012011563164600_qiad126-B75","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI36022","article-title":"NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo","volume":"119","author":"Lakshmikanth","year":"2009","journal-title":"J Clin Invest"},{"issue":"2","key":"2024012011563164600_qiad126-B76","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/icb.2010.78","article-title":"Activating and inhibitory receptors of natural killer cells","volume":"89","author":"Pegram","year":"2011","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"2024012011563164600_qiad126-B77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/cdd.2011.121","article-title":"Fas death receptor signalling: roles of bid and XIAP","volume":"19","author":"Kaufmann","year":"2012","journal-title":"Cell Death & Differentiation"},{"issue":"53","key":"2024012011563164600_qiad126-B78","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","article-title":"TRAIL And apoptosis induction by TNF-family death receptors","volume":"22","author":"Wang","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"2024012011563164600_qiad126-B79","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/s41598-017-02449-x","article-title":"Peptide-specific engagement of the activating NK cell receptor KIR2DS1","volume":"7","author":"Chapel","year":"2017","journal-title":"Sci Rep."},{"issue":"12","key":"2024012011563164600_qiad126-B80","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.4049\/jimmunol.1400859","article-title":"NK Cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival","volume":"193","author":"Gras Navarro","year":"2014","journal-title":"J Immunol"},{"issue":"12","key":"2024012011563164600_qiad126-B81","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.4049\/jimmunol.168.12.6208","article-title":"KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential","volume":"168","author":"Faure","year":"2002","journal-title":"J Immunol"},{"key":"2024012011563164600_qiad126-B82","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fimmu.2012.00326","article-title":"Role of KIR3DS1 in human diseases","volume":"3","author":"K\u00f6rner","year":"2012","journal-title":"Front Immunol"},{"issue":"4","key":"2024012011563164600_qiad126-B83","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxm005","article-title":"CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment","volume":"19","author":"Rabot","year":"2007","journal-title":"Int Immunol."},{"issue":"1","key":"2024012011563164600_qiad126-B84","doi-asserted-by":"crossref","first-page":"9482","DOI":"10.1038\/srep09482","article-title":"ADP-ribose\/TRPM2-mediated Ca2 + signaling is essential for cytolytic degranulation and antitumor activity of natural killer cells","volume":"5","author":"Rah","year":"2015","journal-title":"Sci Rep."},{"issue":"4","key":"2024012011563164600_qiad126-B85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/intimm\/13.4.397","article-title":"Signaling through CD38 induces NK cell activation","volume":"13","author":"Mallone","year":"2001","journal-title":"Int Immunol."},{"issue":"5","key":"2024012011563164600_qiad126-B86","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"2024012011563164600_qiad126-B87","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1074-7613(00)80530-0","article-title":"LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes","volume":"7","author":"Meyaard","year":"1997","journal-title":"Immunity"},{"key":"2024012011563164600_qiad126-B88","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3389\/fimmu.2018.01072","article-title":"Coming of age: cD96 emerges as modulator of immune responses","volume":"9","author":"Georgiev","year":"2018","journal-title":"Front Immunol."},{"key":"2024012011563164600_qiad126-B89","article-title":"Impact of the NK cell receptor LIR-1 (ILT-2\/CD85j\/LILRB1) on cytotoxicity against multiple myeloma","volume":"652130","author":"Heidenreich","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"2024012011563164600_qiad126-B90","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3389\/fimmu.2019.01242","article-title":"PD\/1-PD-Ls checkpoint: insight on the potential role of NK cells","volume":"10","author":"Pesce","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"2024012011563164600_qiad126-B91","doi-asserted-by":"crossref","first-page":"021","DOI":"10.1186\/s13045-021-01112-3","article-title":"Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors","volume":"14","author":"Li","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2024012011563164600_qiad126-B92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.166.1.21","article-title":"Negative regulation of expression and function of Fc\u03b3RIII by CD3\u03b6 in murine NK cells","volume":"166","author":"Arase","year":"2001","journal-title":"The J Immunol"},{"issue":"5","key":"2024012011563164600_qiad126-B93","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/eji.200323896","article-title":"Selective cross-talk among natural cytotoxicity receptors in human natural killer cells","volume":"33","author":"Augugliaro","year":"2003","journal-title":"Eur J Immunol."},{"issue":"1","key":"2024012011563164600_qiad126-B94","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-065X.2008.00720.x","article-title":"DAP10-and DAP12-associated receptors in innate immunity","volume":"227","author":"Lanier","year":"2009","journal-title":"Immunol Rev."},{"issue":"4","key":"2024012011563164600_qiad126-B95","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2567.2009.03045.x","article-title":"Natural killer cells: integrating diversity with function","volume":"126","author":"Cheent","year":"2009","journal-title":"Immunology"},{"issue":"9","key":"2024012011563164600_qiad126-B96","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20042294","article-title":"A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells","volume":"201","author":"Huntington","year":"2005","journal-title":"J Exp Med"},{"issue":"18","key":"2024012011563164600_qiad126-B97","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1073\/pnas.0601851103","article-title":"Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production","volume":"103","author":"Hesslein","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2024012011563164600_qiad126-B98","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ni1325","article-title":"NKG2D-mediated Signaling requires a DAP10-bound grb2-vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells","volume":"7","author":"Upshaw","year":"2006","journal-title":"Nat Immunol."},{"issue":"3","key":"2024012011563164600_qiad126-B99","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxm150","article-title":"Distinct regulatory functions of SLP-76 and MIST in NK cell cytotoxicity and IFN-\u03b3 production","volume":"20","author":"Hidano","year":"2008","journal-title":"Int Immunol."},{"issue":"5","key":"2024012011563164600_qiad126-B100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ceb.2008.05.006","article-title":"The killer's Kiss: the many functions of NK cell immunological synapses","volume":"20","author":"Krzewski","year":"2008","journal-title":"Curr Opin Cell Biol."},{"issue":"9","key":"2024012011563164600_qiad126-B101","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.1701500","article-title":"Single degranulations in NK cells can mediate target cell killing","volume":"200","author":"Gwalani","year":"2018","journal-title":"J Immunol"},{"issue":"10","key":"2024012011563164600_qiad126-B102","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K","article-title":"Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control","volume":"32","author":"Pardo","year":"2002","journal-title":"Eur J Immunol."},{"issue":"1","key":"2024012011563164600_qiad126-B103","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2567.2009.03123.x","article-title":"Natural killer cell cytotoxicity: how do they pull the trigger?","volume":"128","author":"Topham","year":"2009","journal-title":"Immunology"},{"key":"2024012011563164600_qiad126-B104","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","article-title":"Perforin and interferon-\u03b3 activities independently control tumor initiation, growth, and metastasis","volume":"97","author":"Street","year":"2001","journal-title":"Blood"},{"issue":"12","key":"2024012011563164600_qiad126-B105","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1002\/eji.1830251246","article-title":"Perforin dependence of natural killer cell-mediated tumor control in vivo","volume":"25","author":"van den Broek","year":"1995","journal-title":"Eur J Immunol."},{"issue":"1-2","key":"2024012011563164600_qiad126-B106","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a As a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods."},{"issue":"5","key":"2024012011563164600_qiad126-B107","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41590-023-01462-9","article-title":"Tumors evade immune cytotoxicity by altering the surface topology of NK cells","volume":"24","author":"Zheng","year":"2023","journal-title":"Nat Immunol"},{"issue":"8","key":"2024012011563164600_qiad126-B108","doi-asserted-by":"crossref","first-page":"e3001328","DOI":"10.1371\/journal.pbio.3001328","article-title":"Degranulation enhances presynaptic membrane packing, which protects NK cells from perforin-mediated autolysis","volume":"19","author":"Li","year":"2021","journal-title":"PLoS Biol"},{"issue":"7","key":"2024012011563164600_qiad126-B109","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ni.1757","article-title":"Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes","volume":"10","author":"Herz","year":"2009","journal-title":"Nat Immunol"},{"issue":"4","key":"2024012011563164600_qiad126-B110","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.4049\/jimmunol.167.4.2068","article-title":"A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells","volume":"167","author":"Screpanti","year":"2001","journal-title":"J Immunol"},{"issue":"4","key":"2024012011563164600_qiad126-B111","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","article-title":"Activation of NK cell cytotoxicity","volume":"42","author":"Smyth","year":"2005","journal-title":"Mol Immunol."},{"issue":"11","key":"2024012011563164600_qiad126-B112","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4161\/cbt.3.11.1173","article-title":"Death receptor signals to the mitochondria","volume":"3","author":"Khosravi-Far","year":"2004","journal-title":"Cancer Biol Ther."},{"issue":"6","key":"2024012011563164600_qiad126-B113","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1096\/fj.08-111005","article-title":"Life and death by death receptors","volume":"23","author":"Guicciardi","year":"2009","journal-title":"FASEB J"},{"issue":"5381","key":"2024012011563164600_qiad126-B114","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: signaling and modulation","volume":"281","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"issue":"1","key":"2024012011563164600_qiad126-B115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.cdd.4402028","article-title":"Apoptosome: a platform for the activation of initiator caspases","volume":"14","author":"Bao","year":"2007","journal-title":"Cell Death Differ"},{"issue":"43","key":"2024012011563164600_qiad126-B116","doi-asserted-by":"crossref","first-page":"30651","DOI":"10.1074\/jbc.274.43.30651","article-title":"Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45\/inhibitor of caspase-activated DNase inactivation","volume":"274","author":"Wolf","year":"1999","journal-title":"J Biol Chem"},{"issue":"8","key":"2024012011563164600_qiad126-B117","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s12094-023-03120-w","article-title":"PD-L1\/PD-1 blockage enhanced the cytotoxicity of natural killer cell on the non-small cell lung cancer (NSCLC) by granzyme B secretion","volume":"25","author":"Qiao","year":"2023","journal-title":"Clin Transl Oncol"},{"issue":"6013","key":"2024012011563164600_qiad126-B118","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"issue":"5","key":"2024012011563164600_qiad126-B119","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1615\/CritRevImmunol.2014010604","article-title":"NK Cells and their ability to modulate T cells during virus infections","volume":"34","author":"Cook","year":"2014","journal-title":"Critic Rev Immunol"},{"issue":"13","key":"2024012011563164600_qiad126-B120","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon \u03b3-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2024012011563164600_qiad126-B121","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molimm.2017.06.025","article-title":"IL-18\/IL-15\/IL-12 synergy induces elevated and prolonged IFN-\u03b3 production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation","volume":"88","author":"Lusty","year":"2017","journal-title":"Mol Immunol."},{"issue":"9","key":"2024012011563164600_qiad126-B122","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.0.CO;2-G","article-title":"IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-\u03b3 when combined with IL-18","volume":"29","author":"Cai","year":"1999","journal-title":"Eur J Immunol."},{"issue":"3","key":"2024012011563164600_qiad126-B123","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4049\/jimmunol.155.3.1066","article-title":"Regulation of NK cell functions by TGF-beta 1","volume":"155","author":"Bellone","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"2024012011563164600_qiad126-B124","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.immuni.2007.04.001","article-title":"Ready for prime time: NK cell priming by dendritic cells","volume":"26","author":"Long","year":"2007","journal-title":"Immunity"},{"issue":"2","key":"2024012011563164600_qiad126-B125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nri1549","article-title":"Close encounters of different kinds: dendritic cells and NK cells take centre stage","volume":"5","author":"Degli-Esposti","year":"2005","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"2024012011563164600_qiad126-B126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol."},{"issue":"4","key":"2024012011563164600_qiad126-B127","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2007.03.006","article-title":"Dendritic cells prime natural killer cells by trans-presenting interleukin 15","volume":"26","author":"Lucas","year":"2007","journal-title":"Immunity"},{"issue":"12","key":"2024012011563164600_qiad126-B128","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1172\/JCI118726","article-title":"Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines","volume":"97","author":"Bluman","year":"1996","journal-title":"J Clin Invest."},{"issue":"1","key":"2024012011563164600_qiad126-B129","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/0008-5472.CAN-05-2429","article-title":"Natural killer cells produce T cell\u2013recruiting chemokines in response to antibody-coated tumor cells","volume":"66","author":"Roda","year":"2006","journal-title":"Cancer Res."},{"issue":"11","key":"2024012011563164600_qiad126-B130","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2024012011563164600_qiad126-B131","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.191.4.661","article-title":"Differential tumor surveillance by natural killer (Nk) and Nkt cells","volume":"191","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"issue":"11","key":"2024012011563164600_qiad126-B132","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.4049\/jimmunol.162.11.6658","article-title":"Perforin is a major contributor to NK cell control of tumor metastasis","volume":"162","author":"Smyth","year":"1999","journal-title":"J Immunol"},{"issue":"6832","key":"2024012011563164600_qiad126-B133","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"issue":"10","key":"2024012011563164600_qiad126-B134","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20112738","article-title":"Cancer immunoediting by the innate immune system in the absence of adaptive immunity","volume":"209","author":"O'Sullivan","year":"2012","journal-title":"J Exp Med"},{"issue":"1","key":"2024012011563164600_qiad126-B135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","article-title":"Metastatic latency and immune evasion through autocrine inhibition of WNT","volume":"165","author":"Malladi","year":"2016","journal-title":"Cell"},{"issue":"6","key":"2024012011563164600_qiad126-B136","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2159-8290.CD-15-1157","article-title":"Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells","volume":"6","author":"Spiegel","year":"2016","journal-title":"Cancer Discov"},{"issue":"28","key":"2024012011563164600_qiad126-B137","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1200\/JCO.2009.27.6360","article-title":"Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape","volume":"28","author":"Ferris","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6852","key":"2024012011563164600_qiad126-B138","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","article-title":"Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"issue":"4","key":"2024012011563164600_qiad126-B139","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1158\/2326-6066.CIR-16-0234","article-title":"Induction of NKG2D ligands on solid tumors requires tumor-specific CD8(+) T cells and histone acetyltransferases","volume":"5","author":"Hu","year":"2017","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"2024012011563164600_qiad126-B140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","article-title":"NKG2D-deficient Mice are defective in tumor surveillance in models of spontaneous malignancy","volume":"28","author":"Guerra","year":"2008","journal-title":"Immunity"},{"issue":"5","key":"2024012011563164600_qiad126-B141","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.20050994","article-title":"NKG2D Function protects the host from tumor initiation","volume":"202","author":"Smyth","year":"2005","journal-title":"J Exp Med"},{"issue":"7","key":"2024012011563164600_qiad126-B142","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.4049\/jimmunol.1100413","article-title":"Cancer immunoediting of the NK group 2D ligand H60a","volume":"187","author":"O'Sullivan","year":"2011","journal-title":"J Immunol"},{"issue":"6","key":"2024012011563164600_qiad126-B143","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.4049\/jimmunol.1102461","article-title":"Recognition and prevention of tumor metastasis by the NK receptor NKp46\/NCR1","volume":"188","author":"Glasner","year":"2012","journal-title":"J Immunol"},{"issue":"8","key":"2024012011563164600_qiad126-B144","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1158\/0008-5472.CAN-15-1965","article-title":"Inherent and tumor-driven immune tolerance in the prostate microenvironment impairs natural killer cell antitumor activity","volume":"76","author":"Pasero","year":"2016","journal-title":"Cancer Res"},{"issue":"8","key":"2024012011563164600_qiad126-B145","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1158\/0008-5472.CAN-08-3807","article-title":"Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients","volume":"69","author":"M\u00e9nard","year":"2009","journal-title":"Cancer Res"},{"issue":"11","key":"2024012011563164600_qiad126-B146","doi-asserted-by":"crossref","first-page":"e1042202","DOI":"10.1080\/2162402X.2015.1042202","article-title":"Natural killer cell mediated immunosurveillance of pediatric neuroblastoma","volume":"4","author":"Semeraro","year":"2015","journal-title":"Oncoimmunology"},{"issue":"8","key":"2024012011563164600_qiad126-B147","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3390\/ijms18081787","article-title":"Dysfunctional natural killer cells in the aftermath of cancer surgery","volume":"18","author":"Angka","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2024012011563164600_qiad126-B148","first-page":"329","article-title":"The cytolytic and regulatory role of natural killer cells in human neoplasia","volume":"865","author":"Uchida","year":"1986","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"2024012011563164600_qiad126-B149","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.18632\/oncotarget.3965","article-title":"Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer","volume":"6","author":"Pasero","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"2024012011563164600_qiad126-B150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0002-9610(86)90326-0","article-title":"Pharyngeal carcinoma and natural killer cell activity","volume":"152","author":"Schantz","year":"1986","journal-title":"Am J Surg"},{"issue":"7","key":"2024012011563164600_qiad126-B151","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK Cells mediate a crucial graft-versus-leukemia effect in haploidentical-HSCT to cure high-risk acute leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol."},{"issue":"1","key":"2024012011563164600_qiad126-B152","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.immuni.2009.04.019","article-title":"Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition","volume":"31","author":"Li","year":"2009","journal-title":"Immunity"},{"issue":"8","key":"2024012011563164600_qiad126-B153","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.4049\/jimmunol.1202950","article-title":"Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor","volume":"190","author":"L\u00f3pez-Soto","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"2024012011563164600_qiad126-B154","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1038\/ncomms5539","article-title":"Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells","volume":"5","author":"Sathe","year":"2014","journal-title":"Nat Commun."},{"issue":"1","key":"2024012011563164600_qiad126-B155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","article-title":"Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis","volume":"97","author":"Street","year":"2001","journal-title":"Blood"},{"issue":"1","key":"2024012011563164600_qiad126-B156","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/83416","article-title":"Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells","volume":"7","author":"Takeda","year":"2001","journal-title":"Nat Med"},{"issue":"415","key":"2024012011563164600_qiad126-B157","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci Signal"},{"issue":"7636","key":"2024012011563164600_qiad126-B158","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature20792","article-title":"Genome-wide in vivo screen identifies novel host regulators of metastatic colonization","volume":"541","author":"van der Weyden","year":"2017","journal-title":"Nature"},{"issue":"12","key":"2024012011563164600_qiad126-B159","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1084\/jem.20150809","article-title":"Terminal NK cell maturation is controlled by concerted actions of T-bet and zeb2 and is essential for melanoma rejection","volume":"212","author":"van Helden","year":"2015","journal-title":"J Exp Med"},{"issue":"7","key":"2024012011563164600_qiad126-B160","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI92958","article-title":"NK Cell heparanase controls tumor invasion and immune surveillance","volume":"127","author":"Putz","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"2024012011563164600_qiad126-B161","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","article-title":"Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution","volume":"23","author":"Pedersen","year":"2016","journal-title":"Cell Metab"},{"issue":"6","key":"2024012011563164600_qiad126-B162","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ccr.2012.10.023","article-title":"JAK2\/STAT5 Inhibition circumvents resistance to PI3K\/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer","volume":"22","author":"Britschgi","year":"2012","journal-title":"Cancer Cell"},{"issue":"11","key":"2024012011563164600_qiad126-B163","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-14-3198","article-title":"JAK Inhibition impairs NK cell function in myeloproliferative neoplasms","volume":"75","author":"Sch\u00f6nberg","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"2024012011563164600_qiad126-B164","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1038\/ncomms12258","article-title":"Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models","volume":"7","author":"Bottos","year":"2016","journal-title":"Nat Commun."},{"issue":"15","key":"2024012011563164600_qiad126-B165","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood-2014-03-564450","article-title":"Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance","volume":"124","author":"Gotthardt","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2024012011563164600_qiad126-B166","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.celrep.2013.07.012","article-title":"CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance","volume":"4","author":"Putz","year":"2013","journal-title":"Cell Rep"},{"issue":"5","key":"2024012011563164600_qiad126-B167","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2010-06-291633","article-title":"A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development","volume":"117","author":"Eckelhart","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2024012011563164600_qiad126-B168","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1158\/2159-8290.CD-15-0732","article-title":"STAT5 Is a key regulator in NK cells and acts as a molecular switch from tumor surveillance to tumor promotion","volume":"6","author":"Gotthardt","year":"2016","journal-title":"Cancer Discov"},{"issue":"13","key":"2024012011563164600_qiad126-B169","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"key":"2024012011563164600_qiad126-B170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv Immunol"},{"issue":"14","key":"2024012011563164600_qiad126-B171","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","article-title":"Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate","volume":"65","author":"Armeanu","year":"2005","journal-title":"Cancer Res"},{"issue":"25","key":"2024012011563164600_qiad126-B172","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1038\/onc.2009.117","article-title":"HDAC3 Represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer","volume":"28","author":"L\u00f3pez-Soto","year":"2009","journal-title":"Oncogene"},{"issue":"2","key":"2024012011563164600_qiad126-B173","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1535-6108(02)00095-8","article-title":"Epigenetic changes in tumor fas levels determine immune escape and response to therapy","volume":"2","author":"Maecker","year":"2002","journal-title":"Cancer Cell"},{"issue":"13","key":"2024012011563164600_qiad126-B174","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-13-3017","article-title":"Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30","volume":"74","author":"Schlecker","year":"2014","journal-title":"Cancer Res"},{"key":"2024012011563164600_qiad126-B175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fimmu.2015.00097","article-title":"NKG2D Ligands in tumor immunity: two sides of a coin","volume":"6","author":"Zhang","year":"2015","journal-title":"Front Immunol."},{"issue":"7","key":"2024012011563164600_qiad126-B176","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"issue":"4","key":"2024012011563164600_qiad126-B177","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","article-title":"A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment","volume":"78","author":"Young","year":"2018","journal-title":"Cancer Res"},{"key":"2024012011563164600_qiad126-B178","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2018.01859","article-title":"Prostaglandin E2 secreted by thyroid cancer cells contributes to immune Escape through the suppression of natural killer (NK) cell cytotoxicity and NK cell differentiation","volume":"9","author":"Park","year":"2018","journal-title":"Front Immunol."},{"issue":"11","key":"2024012011563164600_qiad126-B179","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00262-011-1064-9","article-title":"Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4","volume":"60","author":"Holt","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"2024012011563164600_qiad126-B180","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"2024012011563164600_qiad126-B181","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.4049\/jimmunol.181.6.3784","article-title":"TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells","volume":"181","author":"Trotta","year":"2008","journal-title":"J Immunol"},{"issue":"7","key":"2024012011563164600_qiad126-B182","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"20","key":"2024012011563164600_qiad126-B183","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.1158\/0008-5472.CAN-04-1627","article-title":"RNA Interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo","volume":"64","author":"Friese","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"2024012011563164600_qiad126-B184","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/neuonc\/nop009","article-title":"TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients","volume":"12","author":"Crane","year":"2010","journal-title":"Neuro Oncol"},{"issue":"11","key":"2024012011563164600_qiad126-B185","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1073\/pnas.1319269111","article-title":"TGF-\u03b2-inducible microRNA-183 silences tumor-associated natural killer cells","volume":"111","author":"Donatelli","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10","key":"2024012011563164600_qiad126-B186","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.4049\/jimmunol.1202693","article-title":"Neuroblastoma-derived TGF-\u03b21 modulates the chemokine receptor repertoire of human resting NK cells","volume":"190","author":"Castriconi","year":"2013","journal-title":"J Immunol"},{"key":"2024012011563164600_qiad126-B187","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3389\/fimmu.2018.02324","article-title":"Molecular mechanisms directing migration and retention of natural killer cells in human tissues","volume":"9","author":"Castriconi","year":"2018","journal-title":"Front Immunol."},{"issue":"3","key":"2024012011563164600_qiad126-B188","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/cmi.2013.2","article-title":"Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy","volume":"10","author":"Pedroza-Pacheco","year":"2013","journal-title":"Cell Mol Immunol."},{"issue":"16","key":"2024012011563164600_qiad126-B189","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-11-3873","article-title":"Primary tumor hypoxia recruits CD11b+\/Ly6Cmed\/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche","volume":"72","author":"Sceneay","year":"2012","journal-title":"Cancer Res"},{"issue":"1","key":"2024012011563164600_qiad126-B190","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"issue":"13","key":"2024012011563164600_qiad126-B191","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Della Chiesa","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2024012011563164600_qiad126-B192","doi-asserted-by":"crossref","first-page":"e202001134","DOI":"10.1083\/jcb.202001134","article-title":"Cancer cells educate natural killer cells to a metastasis-promoting cell state","volume":"219","author":"Chan","year":"2020","journal-title":"J Cell Biol"},{"issue":"2","key":"2024012011563164600_qiad126-B193","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","article-title":"Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression","volume":"28","author":"Cong","year":"2018","journal-title":"Cell Metab"},{"issue":"7655","key":"2024012011563164600_qiad126-B194","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature22367","article-title":"Chromatin states define tumour-specific T cell dysfunction and reprogramming","volume":"545","author":"Philip","year":"2017","journal-title":"Nature"},{"issue":"2","key":"2024012011563164600_qiad126-B195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-Specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"2024012011563164600_qiad126-B196","doi-asserted-by":"crossref","first-page":"e1062968","DOI":"10.1080\/2162402X.2015.1062968","article-title":"Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-beta and miR23a transfer","volume":"5","author":"Berchem","year":"2016","journal-title":"Oncoimmunology"},{"issue":"43","key":"2024012011563164600_qiad126-B197","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1304790110","article-title":"Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia","volume":"110","author":"Baginska","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"2024012011563164600_qiad126-B198","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2217\/imt.11.131","article-title":"Use of allogeneic NK cells for cancer immunotherapy","volume":"3","author":"Geller","year":"2011","journal-title":"Immunotherapy"},{"issue":"5562","key":"2024012011563164600_qiad126-B199","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"1","key":"2024012011563164600_qiad126-B200","doi-asserted-by":"crossref","first-page":"19398","DOI":"10.1038\/s41598-020-76051-z","article-title":"Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance","volume":"10","author":"Calvo","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"2024012011563164600_qiad126-B201","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2024012011563164600_qiad126-B202","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20021847","article-title":"In vivo survival and homeostatic proliferation of natural killer cells","volume":"197","author":"Prlic","year":"2003","journal-title":"J Exp Med"},{"issue":"3-4","key":"2024012011563164600_qiad126-B203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/08830180109054417","article-title":"Ontogeny and expansion of human natural killer cells: clinical implications","volume":"20","author":"Fehniger","year":"2001","journal-title":"Int Rev Immunol"},{"issue":"1","key":"2024012011563164600_qiad126-B204","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/14653249.2010.515582","article-title":"A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer","volume":"13","author":"Geller","year":"2011","journal-title":"Cytotherapy"},{"issue":"1","key":"2024012011563164600_qiad126-B205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-02006-w","article-title":"Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19","volume":"12","author":"Mazini","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"2024012011563164600_qiad126-B206","doi-asserted-by":"crossref","first-page":"e28147","DOI":"10.4161\/onci.28147","article-title":"Are natural killer cells superior CAR drivers?","volume":"3","author":"Klingemann","year":"2014","journal-title":"Oncoimmunology"},{"issue":"2","key":"2024012011563164600_qiad126-B207","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/aps.2017.125","article-title":"Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy","volume":"39","author":"Hu","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"2024012011563164600_qiad126-B208","doi-asserted-by":"crossref","first-page":"1167666","DOI":"10.3389\/fimmu.2023.1167666","article-title":"The application of autologous cancer immunotherapies in the age of memory-NK cells","volume":"14","author":"Lizana-Vasquez","year":"2023","journal-title":"Front Immunol."},{"issue":"1","key":"2024012011563164600_qiad126-B209","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/2159-8290.CD-20-0556","article-title":"Outlook for new CAR-based therapies with a focus on CAR NK cells: what lies beyond CAR-engineered T cells in the race against cancer","volume":"11","author":"Daher","year":"2021","journal-title":"Cancer Discov"},{"issue":"9","key":"2024012011563164600_qiad126-B210","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1111\/cas.14993","article-title":"CAR-NK cell in cancer immunotherapy; A promising frontier","volume":"112","author":"Marofi","year":"2021","journal-title":"Cancer Sci"},{"issue":"1","key":"2024012011563164600_qiad126-B211","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13287-021-02462-y","article-title":"CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies","volume":"12","author":"Marofi","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"2024012011563164600_qiad126-B212","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fimmu.2020.00060","article-title":"Targeting natural killer cells for tumor immunotherapy","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"2024012011563164600_qiad126-B213","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2017.226","article-title":"Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity","volume":"32","author":"Liu","year":"2018","journal-title":"Leukemia"},{"key":"2024012011563164600_qiad126-B214","doi-asserted-by":"crossref","first-page":"4054815","DOI":"10.1155\/2018\/4054815","article-title":"Viral and nonviral engineering of natural killer cells as emerging adoptive cancer immunotherapies","volume":"2018","author":"Matosevic","year":"2018","journal-title":"J Immunol Res"},{"key":"2024012011563164600_qiad126-B215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jconrel.2020.07.016","article-title":"Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment","volume":"326","author":"Lee","year":"2020","journal-title":"J Control Release"},{"issue":"20","key":"2024012011563164600_qiad126-B216","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/0008-5472.CAN-17-0799","article-title":"GSK3 Inhibition drives maturation of NK cells and enhances their antitumor activity","volume":"77","author":"Cichocki","year":"2017","journal-title":"Cancer Res"},{"key":"2024012011563164600_qiad126-B217","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3389\/fimmu.2020.02028","article-title":"Highly efficient generation of transgenically augmented CAR NK cells overexpressing CXCR4","volume":"11","author":"Jamali","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"2024012011563164600_qiad126-B218","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40364-022-00364-6","article-title":"CAR-NK cells for cancer immunotherapy: from bench to bedside","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomark Res."},{"key":"2024012011563164600_qiad126-B219","doi-asserted-by":"crossref","first-page":"825979","DOI":"10.3389\/fimmu.2022.825979","article-title":"Engineered NK cells against cancer and their potential applications beyond","volume":"13","author":"Karvouni","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"2024012011563164600_qiad126-B220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcyt.2014.09.007","article-title":"Challenges of cancer therapy with natural killer cells","volume":"17","author":"Klingemann","year":"2015","journal-title":"Cytotherapy"},{"issue":"1","key":"2024012011563164600_qiad126-B221","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mt.6300028","article-title":"Piggybac transposon-mediated gene transfer in human cells","volume":"15","author":"Wilson","year":"2007","journal-title":"Mol Ther"},{"issue":"1","key":"2024012011563164600_qiad126-B222","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40425-018-0441-8","article-title":"Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells","volume":"6","author":"Wang","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"6","key":"2024012011563164600_qiad126-B223","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-12-3558","article-title":"A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells","volume":"73","author":"Chang","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"2024012011563164600_qiad126-B224","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/2326-6066.CIR-18-0572","article-title":"NK Cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors","volume":"7","author":"Parihar","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"2024012011563164600_qiad126-B225","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.4049\/jimmunol.1400330","article-title":"DAP12-based Activating chimeric antigen receptor for NK cell tumor immunotherapy","volume":"194","author":"T\u00f6pfer","year":"2015","journal-title":"J Immunol"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jleukbio\/advance-article-pdf\/doi\/10.1093\/jleuko\/qiad126\/52783375\/qiad126.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/115\/2\/235\/56260228\/qiad126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/115\/2\/235\/56260228\/qiad126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T11:57:40Z","timestamp":1705751860000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/115\/2\/235\/7306528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":225,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,11]]},"published-print":{"date-parts":[[2024,1,19]]}},"URL":"https:\/\/doi.org\/10.1093\/jleuko\/qiad126","relation":{},"ISSN":["1938-3673"],"issn-type":[{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,10,11]]}}}